Evaluation and comparison between Diltiazem gel 2% and lubricating gel effects on female with sexual dysfunctio

Phase 3

Recruiting

• Conditions: ack or loss of sexual desire.; Hypoactive sexual desire disorder; F52.0

• Registration Number: IRCT20100127003210N21
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

Having sex with a partner for at least one year
Having sexual dysfunction (FSD) for at least 6 months
Patients' Satisfaction to participate in this study

Exclusion Criteria

Unwillingness of patients to continue to participate in the study
History of allergic reactions to the drug
Not taking the drug to treat vaginal atrophy in menopausal women
No pregnancy and lactation
Not recommended in patients with a history of low blood pressure, heart attack and pulmonary embolism

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improving sexual performance and satisfaction in women by measuring the increase of FSFI score. Timepoint: At the beginning of the study, the first week, the second week, the third week, the fourth week, the fifth week. Method of measurement: FSFI.

Secondary Outcome Measures

Name	Time	Method
Improving the quality and satisfaction of sexual intercourse in women. Timepoint: The beginning of the study and the end of the study. Method of measurement: Female Sexual Function Index (FSFI) questionnaire.